Peptides and Compounding: The FDA's New Rules Explained | Ep. 355

3 Sept 2026 · 27 min
27:11

Josh Fritzer and Nicole from Olympia and Wesley Pharmacies explain FDA rules for compounding pharmacies. Seven peptides were recommended for the 503B bulk list, with an FDA decision expected in early fall 2026. They discuss quality controls, how compounders filled GLP-1 shortages, and what clinicians should look for when choosing a pharmacy.

Chapters

More from Dr.

0:23
youtube.com

Aging as the New COVID? 🤔

1d ago
1:09
youtube.com

Extending Healthy Human Life 🌿

2d ago
0:50
youtube.com

Can We Actually Reverse Aging? 🤔 #longevity #aging #reverseaging

5d ago
46:46
youtube.com

Can We Cure Aging In The Next 12-15 Years? | Ep. 358

1w ago
0:48
youtube.com

Aging Could Be Repairable Sooner Than You Think 👩‍🦳👩

1w ago
0:55
youtube.com

Hearing Loss Could Raise Dementia Risk? Protect Your Brain Now! 🧠

1w ago
0:45
youtube.com

Visualizing AI for Human Optimization 🤖

1w ago
0:41
youtube.com

How to Improve Your Memory: A Champion’s Simple System

1w ago
42:24
youtube.com

Stop Losing 80 Percent of What You Learn with Ron White | Ep. 358

2w ago
0:41
youtube.com

The Hidden Muscle Loss Behind Weight Regain

2w ago
0:56
youtube.com

Exercise vs Anti-depressant⁉️

2w ago
See all content